JSPR
Jasper Therapeutics, Inc. NASDAQ Listed Jan 10, 2020$0.91
Mkt Cap $14.8M
52w Low $0.62
4.4% of range
52w High $7.19
50d MA $1.07
200d MA $1.87
P/E (TTM)
-0.2x
EV/EBITDA
-0.1x
P/B
4.3x
Debt/Equity
0.3x
ROE
-1826.1%
P/FCF
-0.5x
RSI (14)
—
ATR (14)
—
Beta
3.20
50d MA
$1.07
200d MA
$1.87
Avg Volume
484.9K
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
2200 Bridge Pkwy · Redwood City, CA 94065 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | -0.79 | -0.32 | +59.5% | 0.90 | -5.0% | -2.6% | -11.1% | -23.6% | -24.0% | -25.8% | — |
| Nov 10, 2025 | AMC | -1.01 | -1.13 | -11.9% | 1.78 | +0.0% | -4.5% | -0.6% | -9.6% | -5.6% | +0.6% | — |
| Aug 13, 2025 | AMC | -1.20 | -1.74 | -45.0% | 2.97 | -2.0% | +2.0% | +4.7% | -1.3% | -4.0% | -4.0% | — |
| May 12, 2025 | AMC | -1.17 | -1.41 | -20.5% | 4.74 | +4.2% | +1.7% | +2.3% | +2.7% | +4.0% | +5.9% | — |
| Feb 27, 2025 | AMC | -1.27 | -1.62 | -27.6% | 5.67 | +0.4% | +4.6% | -1.6% | -2.5% | +0.2% | -4.1% | — |
| Nov 7, 2024 | AMC | -1.09 | -1.24 | -13.8% | 22.69 | -3.0% | +8.1% | +9.0% | +5.2% | +0.5% | -2.6% | — |
| Aug 13, 2024 | AMC | -1.09 | -0.97 | +11.0% | 18.85 | +2.0% | -4.6% | -4.0% | -4.1% | -0.1% | -0.6% | — |
| May 14, 2024 | AMC | -1.26 | -1.03 | +18.3% | 20.92 | -1.5% | +3.3% | +9.2% | +10.0% | +11.0% | +10.4% | — |
| Mar 4, 2024 | AMC | -1.65 | -1.50 | +9.1% | 22.28 | -0.1% | +11.6% | +20.7% | +19.8% | +23.7% | +19.0% | — |
| Nov 9, 2023 | AMC | -1.50 | -1.60 | -6.7% | 7.37 | +3.5% | -6.4% | -10.9% | -14.4% | -22.0% | -17.0% | — |
| Aug 11, 2023 | AMC | -1.30 | -1.50 | -15.4% | 13.90 | +0.0% | -4.3% | +3.6% | -2.2% | -1.4% | +4.3% | — |
| May 12, 2023 | AMC | -1.50 | -1.60 | -6.7% | 15.70 | +0.0% | -0.6% | -1.3% | +5.7% | +13.4% | +13.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $0.88 | $0.89 | +1.3% | -8.7% | -21.5% | -21.9% | -23.8% | -19.3% |
| Nov 11 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $1.78 | $1.78 | +0.0% | -4.5% | -0.6% | -9.6% | -5.6% | +0.6% |
| Sep 22 | BTIG | Maintains | Buy → Buy | — | $2.50 | $2.50 | +0.0% | +1.6% | -4.0% | -6.8% | -6.8% | -1.2% |
| Sep 22 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $2.50 | $2.50 | +0.0% | +1.6% | -4.0% | -6.8% | -6.8% | -1.2% |
| Sep 22 | Evercore ISI | Maintains | Outperform → Outperform | — | $2.50 | $2.50 | +0.0% | +1.6% | -4.0% | -6.8% | -6.8% | -1.2% |
| Aug 15 | UBS | Maintains | Buy → Buy | — | $3.03 | $3.08 | +1.7% | +2.6% | -3.3% | -5.9% | -5.9% | -2.6% |
| Jul 8 | BMO Capital | Downgrade | Outperform → Market Perform | — | $3.04 | $3.11 | +2.3% | -0.7% | +21.1% | +16.8% | +15.5% | +14.1% |
| Jul 8 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $3.04 | $3.11 | +2.3% | -0.7% | +21.1% | +16.8% | +15.5% | +14.1% |
| Jul 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $3.04 | $3.11 | +2.3% | -0.7% | +21.1% | +16.8% | +15.5% | +14.1% |
| Jul 7 | William Blair | Downgrade | Outperform → Market Perform | — | $6.77 | $2.30 | -66.0% | -55.1% | -55.4% | -45.6% | -47.6% | -48.2% |
| Jul 7 | BTIG | Maintains | Buy → Buy | — | $6.77 | $2.30 | -66.0% | -55.1% | -55.4% | -45.6% | -47.6% | -48.2% |
| Jul 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.77 | $2.30 | -66.0% | -55.1% | -55.4% | -45.6% | -47.6% | -48.2% |
| Jul 7 | Cantor Fitzgerald | Downgrade | Overweight → Neutral | — | $6.77 | $2.30 | -66.0% | -55.1% | -55.4% | -45.6% | -47.6% | -48.2% |
| May 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $4.85 | $4.85 | +0.0% | +0.4% | +1.6% | +3.5% | +3.9% | -0.6% |
| May 13 | UBS | Maintains | Buy → Buy | — | $4.74 | $4.94 | +4.2% | +1.7% | +2.3% | +2.7% | +4.0% | +5.9% |
| Mar 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.28 | $5.25 | -0.6% | +1.3% | +2.1% | +1.9% | +4.0% | +7.0% |
| Jan 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $6.99 | $7.12 | +1.9% | +0.9% | -4.3% | -16.0% | -16.7% | -23.6% |
| Jan 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.99 | $7.12 | +1.9% | +0.9% | -4.3% | -16.0% | -16.7% | -23.6% |
| Jan 9 | RBC Capital | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| Jan 6 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $19.27 | $19.82 | +2.9% | +8.3% | -8.1% | -63.7% | -63.4% | -65.3% |
| Dec 23 | RBC Capital | Maintains | Outperform → Outperform | — | $21.57 | $21.58 | +0.0% | +2.5% | +0.6% | +4.3% | +3.2% | -2.9% |
| Oct 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $19.95 | $20.06 | +0.6% | -0.3% | -2.0% | +10.4% | +12.0% | +9.1% |
| Oct 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.58 | $16.62 | +0.2% | +10.3% | +9.7% | +19.6% | +20.9% | +20.0% |
| Oct 15 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $16.58 | $16.62 | +0.2% | +10.3% | +9.7% | +19.6% | +20.9% | +20.0% |
| Sep 27 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $18.84 | $19.07 | +1.2% | -0.1% | -0.2% | -8.2% | -9.7% | -13.1% |
| Aug 26 | Evercore ISI | Maintains | Outperform → Outperform | — | $19.29 | $19.48 | +1.0% | +3.6% | +5.0% | +3.4% | +4.1% | +13.0% |
| Aug 14 | RBC Capital | Maintains | Outperform → Outperform | — | $18.85 | $19.22 | +2.0% | -4.6% | -4.0% | -4.1% | -0.1% | -0.6% |
| Aug 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.77 | $17.13 | +2.1% | +12.4% | +7.2% | +7.9% | +7.8% | +12.3% |
| Aug 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.82 | $15.31 | -9.0% | -1.8% | -1.2% | -3.3% | -2.4% | -2.9% |
| May 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.02 | $23.22 | +0.9% | +0.9% | +0.3% | +3.5% | +3.5% | +3.9% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $20.92 | $20.60 | -1.5% | +3.3% | +9.2% | +10.0% | +11.0% | +10.4% |
| Mar 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $26.90 | $27.50 | +2.2% | -0.7% | +2.4% | -1.4% | -3.3% | -0.4% |
| Oct 11 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $9.07 | $9.00 | -0.8% | +0.3% | -6.3% | -3.9% | -9.0% | -11.8% |
| Aug 13 | Credit Suisse | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| Jun 11 | EF Hutton | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 14 | Credit Suisse | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| May 14 | EF Hutton | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Mar 9 | EF Hutton | Maintains | Buy → Buy | — | $20.00 | $20.20 | +1.0% | -7.0% | -13.5% | -9.0% | -2.0% | -5.0% |
| Mar 9 | Credit Suisse | Maintains | Outperform → Outperform | — | $20.00 | $20.20 | +1.0% | -7.0% | -13.5% | -9.0% | -2.0% | -5.0% |
| Mar 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $20.00 | $20.20 | +1.0% | -7.0% | -13.5% | -9.0% | -2.0% | -5.0% |
| Feb 27 | EF Hutton | Maintains | Buy → Buy | — | $17.60 | $17.50 | -0.6% | +8.5% | +9.7% | +8.0% | +7.4% | +9.1% |
| Feb 15 | EF Hutton | Maintains | Buy → Buy | — | $17.80 | $17.50 | -1.7% | -2.0% | +2.8% | +2.2% | +1.1% | +0.6% |
| Feb 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $19.20 | $19.10 | -0.5% | -1.6% | -3.6% | -8.9% | -7.3% | -4.7% |
| Jan 10 | EF Hutton | Maintains | Buy → Buy | — | $15.90 | $19.60 | +23.3% | +3.8% | +3.8% | +3.8% | +11.9% | +20.1% |
| Jan 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $15.90 | $19.60 | +23.3% | +3.8% | +3.8% | +3.8% | +11.9% | +20.1% |
| Nov 13 | Oppenheimer | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| Nov 1 | EF Hutton | Maintains | Buy → Buy | — | $7.30 | $7.60 | +4.1% | +3.3% | +0.0% | +0.0% | -4.1% | -2.7% |
| Jul 12 | Credit Suisse | Maintains | Outperform → Outperform | — | $22.50 | $23.60 | +4.9% | +2.2% | +2.2% | -11.1% | -13.3% | -13.3% |
| May 12 | Credit Suisse | Maintains | Outperform → Outperform | — | $30.20 | $29.40 | -2.6% | -3.0% | -1.0% | -1.7% | -1.7% | -0.3% |
| Feb 28 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $37.40 | $41.20 | +10.2% | +0.3% | -6.4% | -8.8% | -9.9% | -18.2% |
No insider trades available.
Data updated apr 25, 2026 5:03pm
· Source: massive.com